Pontifax Venture Capital
Investment Details
Investor Type
Venture Capital
Asset Class Focus
Venture Capital
Stage Focus
Seed, Series A, Series B, Growth Stage, Bridge
Geographical Focus
United States, Canada, Middle East, Israel, Western Europe, Northern Europe, Southern Europe
Industries Focus
- Healthcare
- Life Sciences
- Digital Health
- Pharmaceuticals
- Medical Devices
- Diagnostics
- Information Technology
- Biotechnology
- Health Tech
- Medical Research
- Consumer Health
- Medical Equipment
- Therapeutics
- Medical
- Biopharma
Investment Size:
1,000,000 to 20,000,000 USD
Investor Details Founded: 2004
Pontifax Venture Capital is a healthcare-focused venture capital firm investing in transformative life sciences technologies at all development stages. With over $1.2 billion under management, Pontifax has supported approximately 75 startups and established 15 successful companies in the life sciences sector. The firm seeks groundbreaking innovations in healthcare, pharmaceuticals, biotechnology, and related fields, aiming to address substantial unmet needs through its investments.
Pontifax's investment strategy encompasses various stages, including Seed, Series A, Series B, Growth Stage, and Bridge financing. The firm operates across multiple regions, including Israel, the United States, Canada, and parts of Europe, such as Northern, Southern, and Western Europe. Its portfolio spans a wide array of industries within the life sciences sector, including biotechnology, healthcare, medical devices, pharmaceuticals, digital health, and medical equipment.
The firm's approach is hands-on, providing strategic direction, capital markets expertise, and M&A guidance to its portfolio companies. Pontifax's commitment to nurturing innovative healthcare solutions has led to the establishment of numerous successful companies, reflecting its dedication to advancing the life sciences industry through strategic investments and active portfolio management.
Requirements
- Innovative life sciences technologies
- Strong management teams
- Potential for significant impact in healthcare
Contact
[Official Website Hidden]
[LinkedIn Profile Hidden]
[HQ Location Hidden]
[Email Hidden]
[Contact Number Hidden]
Portfolio Companies
- Alcide
- BioCatch
- CureMetrix
- DarioHealth
- Enlivex
- Glycominds
- Imunon
- Kamada
- MediWound
- MediTouch
Mentioned In
-
$24.95
-
$24.95
-
$19.95
-
$49.95
-
$19.95
-
$39.95
-
$99.00
Claim this Investor
Are you an official representative of Pontifax Venture Capital?
Claim this investor to update information, manage your profile, and get a verified seal.
Claim